Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients with CML-CP: The ENRICH Study

Jorge E. Cortes, Jeffrey H. Lipton, Carole B. Miller, Lambert Busque, Luke P. Akard, Javier Pinilla-Ibarz, Christopher Keir, Ghulam Warsi, Felice P. Lin, Michael J. Mauro

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients with CML-CP: The ENRICH Study'. Together they form a unique fingerprint.

Medicine & Life Sciences